Foley Secures Rare Inter Partes Review Wins for Patent Owner Supernus Pharmaceuticals
10 December 2014
Foley secured three significant inter partes review victories on behalf of Supernus Pharmaceuticals, Inc. and Galderma S.A. for a pharmaceutical product, which represents one of the first inter partes reviews to reach a final decision in favor of the patent owner, where the patents were the subject of a parallel Hatch-Waxman patent litigation. The inter partes reviews were filed by a “generic” company that filed an Abbreviated New Drug application to market a generic version of the product Oracea®.
The Foley team, led by Stephen Maebius, included Andrew Baluch, George Quillin, and Sunit Talapatra.
People
Related News
24 October 2024
Press Releases
Foley Publishes a ‘How-To’ Manufacturing Guide on Today’s Pressing Legal Challenges and Those that Lie Ahead
Foley & Lardner LLP today released its 2024 End-to-End Manufacturing Manual, a compilation of essays focused on helping companies navigate the ever-changing future of manufacturing.
23 October 2024
Press Releases
Foley Strengthens Florida Presence with Addition of Two Corporate Partners
Foley & Lardner LLP announced today that it has expanded its Innovative Technology Sector and Transactions Practice Group with the addition of partners Joshua Ehrenfeld and Charles Curley to the firm’s Jacksonville office.
14 October 2024
Press Releases
Foley Releases eBook Exploring Developments and Impacts of Artificial Intelligence Advancements
Foley & Lardner LLP today published its second annual eBook that examines Artificial Intelligence with insights on how to navigate the rapidly evolving landscape of this technology as it transforms industries across all economic sectors.